Search results
Results from the WOW.Com Content Network
The Misuse of Drugs Act 1973 is a statute of the Parliament of Singapore that enables authorities to prosecute offenders for crimes involving illegal drugs.The law is designed specifically to grant the Government of Singapore, through its agencies such as the Central Narcotics Bureau, enforcement powers to combat offences such as the trafficking, importation or exportation, possession, and ...
"The Dangerous Drugs Act (i.e. DDO) was enacted about 21 years ago and the controls provided therein are grossly inadequate for the 70's, with the introduction of a host of new drugs of medical value if properly used." The need was exacerbated by Singapore's geographical location and development into a trading hub.
More than 400 people were executed in Singapore, mostly for drug trafficking, between 1991 and 2004. Statistically, Singapore has one of the highest execution rates in the world relative to its population. [1] Science fiction writer William Gibson famously described Singapore as "Disneyland with the death penalty".
The Health Sciences Authority headquarters at Outram Road, Singapore. HSA was formed on 1 April 2001 with the integration of five specialised agencies under the Ministry of Health: the Centre for Drug Evaluation; Institute of Science and Forensic Medicine; National Pharmaceutical Administration; Product Regulation Department; and Singapore Blood Transfusion Service.
Synapxe Pte Ltd, formerly known as Integrated Health Information System (IHiS), is a wholly-owned subsidiary of MOH Holdings Pte Ltd, the holding company through which the Singapore Ministry of Health owns corporatised institutions in the public healthcare sector.
The drug control treaties mandates four international bodies: the Board, the World Health Organization, the Secretary-General of the United Nations (nowadays represented by the United Nations Office on Drugs and Crime), and the Commission on Narcotic Drugs. The commission has power to influence drug control policy by advising other bodies and ...
However, the associated Misuse of Drugs Regulations 2001 [6] does exempt products containing less than 1 mg of a controlled substance (1 ug for lysergide and derivatives) so long as a number of requirements are met, including that it cannot be recovered by readily applicable means, does not pose a risk to human health and is not meant for ...
The Singapore's National Research Foundation (NRF) announced on January 10, 2018 that it would develop synthetic medicinal cannabinoids, or chemical compounds found in the marijuana plant, to eventually help treat diseases such as Alzheimer's and Parkinson's. Part of a broader S$25 million ($19 million) investment by the body into synthetic ...